1-(2,3,5-Tri-O-acetyl-beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxylic acid, methyl ester

We are 1-(2,3,5-Tri-O-acetyl-beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxylic acid, methyl ester CAS:39925-10-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-(2,3,5-Tri-O-acetyl-beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxylic acid, methyl ester
CAS.NO:39925-10-5
Synonyms:1-(2,3,5-Tri-O-acetyl-beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxylic acid, methyl ester
1H-1,2,4-triazole-5-carboxylic acid
1-(2,3,5-Tri-O-Acetyl-Β-D-Ribofuranosyl)-1H-1,2,4-Triazole-3-Carboxylic Acid, Methyl Ester
METHYL 1-(2,3,5-TRI-O-ACETHYL-BETA-D-RIBOFURANOSYL)-1,2,4-TRIAZOLE-3-CARBOXYLATE
 
Physical and Chemical Properties:
Melting Point 103-107ºC(lit.)
Molecular Formula C15H19N3O9
Molecular Weight 385.32600
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ribavirin(CAS:36791-04-5).

1-(2,3,5-Tri-O-acetyl-beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxylic acid, methyl ester


Related News: Any drug or medication is composed of two components.Éster terc-butílico del ácido 2- (metilsulfonil) -2,6-dihidropirrolo [3,4-c] pirazol-5 (4H) -carboxílico CAS:1226781-82-3 Any drug or medication is composed of two components.3-BAP2NA-B CAS:944801-33-6 Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells.2022-85-7 Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.

Related Products
Product Name
ethyl 3-cyclopropyl-3-oxopropanoate View Details
N-methylpentan-1-amine View Details
(3R,4S)-1-t-Boc-3-[(triethylsilyl)oxy]-4-phenyl-2-azatidinone View Details
1,5-Naphthalene diisocyanate manufacturer Cetrorelix acetate manufacturer Octadecyl acrylate manufacturer 2-Chloro-4,5-difluorobenzaldehyde manufacturer 3-Ethynylimidazo[1,2-b]pyridazine manufacturer